Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[The hepatorenal syndrome]

S Møller1, J Abrahamsen, H Ring-Larsen

  • 1Hvidovre Hospital, klinisk fysiologisk/nuklearmedicinsk afdeling 239, København.

Ugeskrift for Laeger
|May 29, 1995
PubMed
Summary

Hepatorenal syndrome (HRS) is kidney failure in liver disease, marked by low GFR and sodium retention. Liver transplantation offers the ultimate treatment for this condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NANOCIS®: Possible errors in the summary of product characteristics quality control method and a suggested alternative method.

Nuclear medicine and biology·2022
Same author

Abolished ventilation and perfusion of lung caused by blood clot in the left main bronchus: auto-downregulation of pulmonary arterial blood supply.

BMJ case reports·2015
Same author

Estimating the glomerular filtration rate using serum cystatin C levels in patients with spinal cord injuries.

Spinal cord·2012
Same author

Does comprilan bandage have any influence on peripheral perfusion in patients with oedema?

Clinical physiology and functional imaging·2010
Same author

Ribavirin dosage in patients with HCV genotypes 2 and 3 who completed short therapy with peg-interferon alpha-2b and ribavirin.

Alimentary pharmacology & therapeutics·2010
Same author

Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites.

Gut·2009

Area of Science:

  • Nephrology
  • Hepatology
  • Gastroenterology

Background:

  • Renal dysfunction and abnormal sodium-water handling are common in liver disease.
  • Hepatorenal syndrome (HRS) is a functional renal failure with decreased glomerular filtration rate (GFR), sodium retention, and oliguria.
  • Reduced renal blood flow (RBF), particularly in the renal cortex, is a key pathogenic feature of HRS.

Purpose of the Study:

  • To define hepatorenal syndrome (HRS) and its characteristics.
  • To explore the contributing factors in the pathogenesis of HRS.
  • To discuss the prognosis and treatment options for HRS.

Main Methods:

  • Literature review and synthesis of existing knowledge on HRS.
  • Analysis of pathogenic factors including liver function, hemodynamics, and neuro-humoral regulation.
  • Evaluation of therapeutic interventions and their efficacy.

Main Results:

  • HRS is characterized by decreased GFR, sodium retention, and oliguria due to reduced RBF.
  • Pathogenesis involves decreased liver function, deranged hemodynamics (blood pressure, volume, flow distribution), and altered neuro-humoral regulation.
  • Therapies like peritoneovenous shunt and plasma expansion show limited success, primarily in early stages.

Conclusions:

  • The prognosis for HRS is poor, with disappointing therapeutic outcomes.
  • Future research should focus on addressing reduced liver function and hemodynamic abnormalities, especially renal vasoconstriction.
  • Liver transplantation remains the definitive treatment for HRS.

Related Experiment Videos